Teclison Ltd.

This study tests a two-part treatment for people with colorectal or non-small cell lung cancer that has spread to the liver and hasn't responded to standard therapies. The treatment combines a liver-directed procedure (TATE) that delivers a drug directly to tumors with pembrolizu…

This early-phase trial tests a drug called tirapazamine, which becomes active in low-oxygen areas, combined with a procedure that blocks blood flow to liver tumors (embolization). The goal is to find the best dose and see how well the treatment shrinks tumors. The study includes …

This study is testing a two-step treatment for people with advanced liver cancer or stomach cancer that has spread to the liver and has stopped responding to standard therapies. First, doctors will deliver a cancer-fighting drug directly into the liver tumor's blood supply. Then,…